The next‐generation BET inhibitor, PLX51107, delays melanoma growth in a CD8‐mediated manner
DA Erkes, CO Field, C Capparelli… - Pigment cell & …, 2019 - Wiley Online Library
Epigenetic agents such as bromodomain and extra‐terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner
DA Erkes, CO Field, C Capparelli… - Pigment cell & …, 2019 - pubmed.ncbi.nlm.nih.gov
Epigenetic agents such as bromodomain and extra-terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
The next‐generation BET inhibitor, PLX51107, delays melanoma growth in a CD8‐mediated manner.
DA Erkes, CO Field, C Capparelli… - Pigment Cell & …, 2019 - search.ebscohost.com
Epigenetic agents such as bromodomain and extra‐terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
[HTML][HTML] The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner
DA Erkes, CO Field, C Capparelli, M Tiago… - Pigment cell & …, 2019 - ncbi.nlm.nih.gov
Epigenetic agents such as bromodomain and extra terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity …
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner
DA Erkes, CO Field, C Capparelli… - Pigment cell and …, 2019 - researchdiscovery.drexel.edu
Epigenetic agents such as bromodomain and extra-terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on antitumor immunity …
[PDF][PDF] The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner
DA Erkes, CO Field, C Capparelli, M Tiago… - … Cell Melanoma Res, 2019 - academia.edu
Epigenetic agents such as bromodomain and extra terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity …
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.
DA Erkes, CO Field, C Capparelli, M Tiago… - Pigment Cell & …, 2019 - europepmc.org
Epigenetic agents such as bromodomain and extra terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity …
[PDF][PDF] PIGMENT CELL & MELANOMA Research
DA Erkes, CO Field, C Capparelli, M Tiago, TJ Purwin… - researchgate.net
Epigenetic agents such as bromodomain and extra‐terminal region inhibitors (BETi) slow
tumor growth via tumor intrinsic alterations; however, their effects on antitu‐mor immunity …
tumor growth via tumor intrinsic alterations; however, their effects on antitu‐mor immunity …